The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).

VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

BTOG 2020 | Molecular testing for lung cancer in England

Name: Molecular testing for lung cancer in England
Uploaded: 2020-01-30T00:00:00Z
Duration: 2 min 20 s
Description: Sanjay Popat, BSc, MBBS, FRCP, PhD, The Royal Marsden NHS Foundation Trust, London, UK, outlines the first national study investigating the efficacy and outcomes of molecular testing in patients with advanced non-small cell lung cancer (NSCLC) in England. This interview took place at the 18th British Thoracic Oncology Group (BTOG) 2020 congress held in Dublin, UK.

Sanjay Popat • 30 Jan 2020

BTOG 2020

Lung Cancer Non-Small Cell Lung Cancer

Sanjay Popat, BSc, MBBS, FRCP, PhD, The Royal Marsden NHS Foundation Trust, London, UK, outlines the first national study investigating the efficacy and outcomes of molecular testing in patients with advanced non-small cell lung cancer (NSCLC) in England. This interview took place at the 18th British Thoracic Oncology Group (BTOG) 2020 congress held in Dublin, UK.